Tactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
Tactile Medical (TCMD) has announced its upcoming participation in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference, scheduled for March 17th-20th, 2025. The company's management will deliver a virtual presentation on Tuesday, March 18th at 12:00 p.m. Eastern Time.
The presentation will be accessible via live audio webcast in the 'Events & Webcasts' section of Tactile Medical's investor relations website. Investors can access the webcast at investors.tactilemedical.com, with a replay option available after the conference.
Tactile Medical specializes in developing and marketing at-home therapies for chronic conditions including lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease. The company focuses on enabling patients to better manage their conditions through home-based care, while collaborating with clinicians to expand clinical evidence and improve healthcare outcomes.
Tactile Medical (TCMD) ha annunciato la sua prossima partecipazione alla 35ª Conferenza Annuale MedTech & Servizi di Oppenheimer, prevista dal 17 al 20 marzo 2025. La direzione dell'azienda presenterà una relazione virtuale martedì 18 marzo alle 12:00 ora orientale.
La presentazione sarà accessibile tramite webcast audio dal vivo nella sezione 'Eventi & Webcast' del sito web delle relazioni con gli investitori di Tactile Medical. Gli investitori possono accedere al webcast su investors.tactilemedical.com, con un'opzione di replay disponibile dopo la conferenza.
Tactile Medical è specializzata nello sviluppo e nella commercializzazione di terapie domiciliari per condizioni croniche tra cui linfedema, lipedema, insufficienza venosa cronica e malattia polmonare cronica. L'azienda si concentra sull'aiutare i pazienti a gestire meglio le loro condizioni attraverso cure a domicilio, collaborando con i clinici per ampliare le evidenze cliniche e migliorare i risultati sanitari.
Tactile Medical (TCMD) ha anunciado su próxima participación en la 35ª Conferencia Anual de MedTech y Servicios de Oppenheimer, programada del 17 al 20 de marzo de 2025. La dirección de la empresa realizará una presentación virtual el martes 18 de marzo a las 12:00 p.m. hora del Este.
La presentación será accesible a través de un webcast de audio en vivo en la sección 'Eventos y Webcasts' del sitio web de relaciones con inversores de Tactile Medical. Los inversores pueden acceder al webcast en investors.tactilemedical.com, con una opción de repetición disponible después de la conferencia.
Tactile Medical se especializa en el desarrollo y comercialización de terapias en el hogar para condiciones crónicas, incluyendo linfedema, lipedema, insuficiencia venosa crónica y enfermedad pulmonar crónica. La empresa se enfoca en permitir que los pacientes gestionen mejor sus condiciones a través de la atención domiciliaria, mientras colabora con clínicos para ampliar la evidencia clínica y mejorar los resultados en salud.
택타일 메디컬(TCMD)은 2025년 3월 17일부터 20일까지 예정된 오펜하이머 제35회 연례 헬스케어 메드텍 및 서비스 컨퍼런스에 참가할 것이라고 발표했습니다. 회사의 경영진은 3월 18일 화요일 오후 12시(동부 표준시)에 가상 발표를 진행할 예정입니다.
발표는 택타일 메디컬의 투자자 관계 웹사이트 '이벤트 및 웹캐스트' 섹션을 통해 실시간 오디오 웹캐스트로 접근할 수 있습니다. 투자자들은 investors.tactilemedical.com에서 웹캐스트에 접속할 수 있으며, 컨퍼런스 후 다시 보기 옵션도 제공됩니다.
택타일 메디컬은 림프부종, 지방부종, 만성 정맥 기능 부전 및 만성 폐 질환을 포함한 만성 질환을 위한 홈 치료법을 개발하고 마케팅하는 데 전문화되어 있습니다. 이 회사는 환자들이 자택에서 치료를 통해 자신의 상태를 더 잘 관리할 수 있도록 지원하며, 임상의와 협력하여 임상 증거를 확장하고 의료 결과를 개선하는 데 집중하고 있습니다.
Tactile Medical (TCMD) a annoncé sa prochaine participation à la 35ème Conférence Annuelle MedTech & Services d'Oppenheimer, prévue du 17 au 20 mars 2025. La direction de l'entreprise fera une présentation virtuelle le mardi 18 mars à 12h00, heure de l'Est.
La présentation sera accessible via un webcast audio en direct dans la section 'Événements & Webcasts' du site web des relations investisseurs de Tactile Medical. Les investisseurs peuvent accéder au webcast sur investors.tactilemedical.com, avec une option de rediffusion disponible après la conférence.
Tactile Medical se spécialise dans le développement et la commercialisation de thérapies à domicile pour des conditions chroniques telles que lymphedème, lipœdème, insuffisance veineuse chronique et maladie pulmonaire chronique. L'entreprise se concentre sur l'autonomisation des patients pour mieux gérer leurs conditions grâce à des soins à domicile, tout en collaborant avec des cliniciens pour élargir les preuves cliniques et améliorer les résultats en matière de santé.
Tactile Medical (TCMD) hat seine bevorstehende Teilnahme an der 35. jährlichen MedTech- und Dienstleistungskonferenz von Oppenheimer angekündigt, die vom 17. bis 20. März 2025 stattfinden wird. Das Management des Unternehmens wird am Dienstag, den 18. März um 12:00 Uhr Eastern Time eine virtuelle Präsentation halten.
Die Präsentation wird über einen Live-Audio-Webcast im Bereich 'Veranstaltungen & Webcasts' der Investor-Relations-Website von Tactile Medical zugänglich sein. Investoren können den Webcast unter investors.tactilemedical.com abrufen, mit einer Möglichkeit zur Wiederholung nach der Konferenz.
Tactile Medical ist auf die Entwicklung und Vermarktung von Therapien für zu Hause bei chronischen Erkrankungen spezialisiert, darunter Lymphödem, Lipödem, chronische venöse Insuffizienz und chronische Lungenerkrankung. Das Unternehmen konzentriert sich darauf, Patienten zu ermöglichen, ihre Erkrankungen besser zu managen, während es mit Klinikern zusammenarbeitet, um klinische Beweise zu erweitern und die Gesundheitsresultate zu verbessern.
- None.
- None.
MINNEAPOLIS, March 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference, which is being virtually held from March 17th – 20th. Management will participate in a virtual presentation on Tuesday, March 18th at 12:00 p.m. Eastern Time.
A live audio webcast of the presentation will be accessible under the “Events & Webcasts” section of the Company's investor relations website at http://investors.tactilemedical.com. An archive of the webcast will be available for replay following the conference.
About Tactile Systems Technology, Inc. (DBA Tactile Medical)
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com
FAQ
When is Tactile Medical (TCMD) presenting at the Oppenheimer Healthcare Conference 2025?
How can investors access TCMD's Oppenheimer Conference presentation?
What medical conditions does Tactile Medical (TCMD) treat with their at-home therapies?
What is the main business focus of Tactile Medical (TCMD)?
